Medicare Enrolled
Dr. Gerard Criner, MD
Pulmonary Disease · Philadelphia, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Criner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Criner?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Criner
Dr. Gerard Criner is a pulmonary disease specialist in Philadelphia, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Criner performed 1,332 Medicare services across 823 unique beneficiaries.
Between the years covered by Open Payments, Dr. Criner received a total of $741,903 from 41 pharmaceutical and/or device companies across 486 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Criner is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 18% volume in PA
$741,903 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,332
Medicare services
Top 18% in PA for pulmonary disease
823
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~67 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
328 | $102 | $200 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
144 | $65 | $140 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
131 | $12 | $50 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
117 | $143 | $260 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
111 | $178 | $610 |
| Bronchoscopy A diagnostic exam of the lung airways using an endoscope to visually inspect the inside of the lungs and airways. |
67 | $102 | $440 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
56 | $131 | $300 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
53 | $99 | $200 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
48 | $7 | $30 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
41 | $7 | $30 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
41 | $68 | $160 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
40 | $18 | $80 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
28 | $10 | $40 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
27 | $8 | $50 |
| Bronchial valve insertion for lung air leak A procedure using an endoscope to insert a valve into the lung airway to assess for air leaks and determine airway size. |
17 | $161 | $700 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
17 | $72 | $100 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
15 | $74 | $450 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
15 | $32 | $40 |
| Computer-assisted navigation of lung airways This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation. |
14 | $79 | $320 |
| Bronchoscopy with ultrasound and growth treatment A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found. |
11 | $55 | $230 |
| New patient office visit, complex (60-74 min) | 11 | $138 | $445 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
13.7% medium
85.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$741,903
Total received (2018-2024)
Avg $105,986/year across 7 years
Top 0% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
486
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$495,652 (66.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$129,554 (17.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$80,743 (10.9%)
Scientific / Research
Research funding and grants
$35,955 (4.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$97,219
2023
$58,830
2022
$22,302
2021
$71,450
2020
$64,126
2019
$209,013
2018
$218,964
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$26,200
Pulmonx Corporation
$25,227
GlaxoSmithKline, LLC.
$16,575
Olympus Corporation of the Americas
$12,819
Genentech USA, Inc.
$5,796
AstraZeneca Pharmaceuticals LP
$3,610
F. Hoffmann-La Roche AG
$3,300
Aero US Inc
$2,100
E.R. Squibb & Sons, L.L.C.
$700
Boehringer Ingelheim Pharmaceuticals, Inc.
$600
Regeneron Healthcare Solutions, Inc.
$214
Boston Scientific Corporation
$78
Top 3 companies account for 69.9% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$184,379
AstraZeneca UK Limited
$105,724
Pulmonx Corporation
$89,428
Olympus Corporation of the Americas
$70,442
Boehringer Ingelheim Pharmaceuticals, Inc.
$48,552
Spiration, Inc.
$36,731
PneumRx, Inc
$33,744
GENZYME CORPORATION
$30,210
Fisher & Paykel Healthcare Limited
$23,639
AstraZeneca Pharmaceuticals LP
$15,157
Olympus America Inc.
$13,320
Gilead Sciences, Inc.
$10,500
Boehringer Ingelheim International GmbH
$9,097
BTG International, Inc.
$8,988
Intuitive Surgical, Inc.
$7,847
SANOFI US SERVICES INC.
$6,862
Merck Sharp & Dohme Corporation
$5,826
Genentech USA, Inc.
$5,796
Novartis Pharma AG
$4,457
Regeneron Healthcare Solutions, Inc.
$4,202
Philips Electronics North America Corporation
$3,829
Zambon USA Ltd.
$3,750
F. Hoffmann-La Roche AG
$3,300
Merck Sharp & Dohme LLC
$3,081
Aero US Inc
$2,100
Janssen Scientific Affairs, LLC
$1,725
NOVARTIS PHARMACEUTICALS CORPORATION
$1,598
Gyrus ACMI, Inc.
$1,210
CSA Medical, Inc
$1,206
PFIZER INC.
$1,200
Medtronic Vascular, Inc.
$1,140
Beyond Air, Inc.
$1,000
E.R. Squibb & Sons, L.L.C.
$700
Amgen Inc.
$500
Auris Health, Inc.
$313
Broncus Medical
$177
Boston Scientific Corporation
$78
Ethicon Inc.
$52
Resmed Corp
$20
Covidien LP
$13
Ambu Inc.
$10
Top 3 companies account for 51.2% of all-time payments
Associated products mentioned in payments ›
120V · 60Hz · AEROGEN SOLO NEBULIZER SYSTEM · AIR 11 · ANORO · CHARTIS CATHETER · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Da Vinci Surgical System · FASENRA · FISHER & PAYKEL HEALTHCARE · Lungfit · MK-5475 · Monarch Platform · NUCALA · OFEV · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · Olympus Bronchoscopes · Olympus Capital Accessories · Olympus EBUS Bronchoscopes · Olympus Respiratory Accessories · Other Resp ServSales · PAXLOVID · PNEUMRX COILS · PT100US/myAIRVO 2 · PULMICORT RESPULES · Pulmonx Endobronchial Valve EBV · QVA149A · SINGLE USE SUCTION VALVE (Sterile) · SPIRIVA · SPIRIVA RESPIMAT · SPiN Thoracic Navigation System · SPiN Vision Video Processor · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · Spiration Valve System · VORAXAZE · Veklury · Wellcentive Undiv · ZEPHYR ENDOBRONCHIAL VALVE · superDimension
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (67%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for pulmonary disease in PA.
Geographic Context
Pulmonary diseases within 10 mi
272
Per 100K population
17.2
County median income
$60,698
Nearest hospital
TEMPLE UNIVERSITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Criner is a clinical cardiology specialist, with above-average Medicare volume (top 18% in PA), with consulting-driven industry engagement in the top 0% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Criner experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Criner performed 328 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Criner receive payments from pharmaceutical companies?
Yes. Dr. Criner received a total of $741,903 from 41 companies across 486 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Criner's costs compare to other pulmonary diseases in Philadelphia?
Dr. Criner's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Criner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Philadelphia
Browse pulmonary diseases in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in PA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in PA
Which PA pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca UK Limited Payments to Doctors
See all physicians who received payments from AstraZeneca UK Limited.
By company
Pulmonx Corporation Payments to Doctors
See all physicians who received payments from Pulmonx Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology